UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000052494
Receipt number R000059792
Scientific Title Breathing-swallowing discoordination in lung transplantation candidates and lung transplant patients
Date of disclosure of the study information 2023/11/01
Last modified on 2023/10/13 17:31:39

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Breathing-swallowing discoordination in lung transplantation candidates and lung transplant patients

Acronym

Breathing-swallowing discoordination in lung transplantation candidates and lung transplant patients

Scientific Title

Breathing-swallowing discoordination in lung transplantation candidates and lung transplant patients

Scientific Title:Acronym

Breathing-swallowing discoordination in lung transplantation candidates and lung transplant patients

Region

Japan


Condition

Condition

Chronic progressive lung disease with chronic respiratory failure

Classification by specialty

Pneumology Chest surgery Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

This study aims to prospectively validate breathing-swallowing patterns in patients with end-stage respiratory failure requiring lung transplantation and in post-lung transplant patients using swallow monitoring.

Basic objectives2

Others

Basic objectives -Others

This study aims to monitor swallowing status before and after lung transplantation using a swallow monitor to identify risk factors such as pre-transplant exacerbations and post-transplant rejection.

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

breathing-swallowing pattern

Key secondary outcomes

Exacerbation or rejection at 1 year post-registration


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

(1) Patients with chronic progressive lung disease with chronic respiratory failure
(2) Patients scheduled to be registered for brain-dead lung transplantation or immediately after brain-dead lung transplantation
(3) Age: 18 years or older at the time of consent
(4) Patients who have been fully informed about the participation in this study, and who have given their free and voluntary written consent based on a thorough understanding of the study.

Key exclusion criteria

(1) Obvious dysphagia at the time consent is obtained
(2) History of aspiration pneumonia
(3) Cerebrovascular disease
(4) Using dopamine agonists
(5) After a tracheotomy

Target sample size

80


Research contact person

Name of lead principal investigator

1st name Keita
Middle name
Last name Nakao

Organization

The University of Tokyo Hospital

Division name

Department of Thoracic Surgery

Zip code

113-8655

Address

7-3-1, Hongo Bunkyo-ku, Tokyo, JAPAN

TEL

03-3815-5411

Email

nakaok-sur@h.u-tokyo.ac.jp


Public contact

Name of contact person

1st name Takafumi
Middle name
Last name Yamaya

Organization

The University of Tokyo Hospital

Division name

Department of Thoracic Surgery

Zip code

113-8655

Address

7-3-1, Hongo Bunkyo-ku, Tokyo, JAPAN

TEL

03-3815-5411

Homepage URL


Email

yamayat-sur@h.u-tokyo.ac.jp


Sponsor or person

Institute

The University of Tokyo Hospital

Institute

Department

Personal name

Keita Nakao


Funding Source

Organization

Japan Agency for Medical Research and Development

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor

Hyogo Medical University
Advanced Medical Engineering Research Institute, University of Hyogo

Name of secondary funder(s)



IRB Contact (For public release)

Organization

The University of Tokyo Hospital

Address

7-3-1, Hongo Bunkyo-ku, Tokyo, JAPAN

Tel

03-3815-5411

Email

nakaok-sur@h.u-tokyo.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

東京大学医学部附属病院


Other administrative information

Date of disclosure of the study information

2023 Year 11 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2023 Year 08 Month 01 Day

Date of IRB

2023 Year 09 Month 14 Day

Anticipated trial start date

2023 Year 10 Month 01 Day

Last follow-up date

2025 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Cases are being accumulated.


Management information

Registered date

2023 Year 10 Month 13 Day

Last modified on

2023 Year 10 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000059792


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name